Liposome News and Research

Latest Liposome News and Research

VELCADE sNDA receives FDA approval

VELCADE sNDA receives FDA approval

Therapure Biopharma to fill/finish nimotuzumab at its Canadian GMP certified fill suite

Therapure Biopharma to fill/finish nimotuzumab at its Canadian GMP certified fill suite

Update on proposed transaction that will lead to the merger of Cytopia into YM BioSciences provided

Update on proposed transaction that will lead to the merger of Cytopia into YM BioSciences provided

Initiation of multi-national Phase III study of Stimuvax announced

Initiation of multi-national Phase III study of Stimuvax announced

FDA approves Azaya Therapeutics' Taxotere for Phase I clinical study

FDA approves Azaya Therapeutics' Taxotere for Phase I clinical study

Merck commences Stimuvax Phase 3 trial in Asian patients with NSCLC

Merck commences Stimuvax Phase 3 trial in Asian patients with NSCLC

YM BioSciences announces results of collaborative antibody development program

YM BioSciences announces results of collaborative antibody development program

VERTICAL Phase II trial results for NHL released

VERTICAL Phase II trial results for NHL released

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Interim data from Celator Pharmaceuticals' CPX-351 trial presented at the ASH meeting

Interim data from Celator Pharmaceuticals' CPX-351 trial presented at the ASH meeting

VELCADE based regimens are cost-effective for payers and patients, finds study

VELCADE based regimens are cost-effective for payers and patients, finds study

Update on Celsion's ThermoDox Phase III “HEAT” trial for HCC

Update on Celsion's ThermoDox Phase III “HEAT” trial for HCC

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

NeoPharm presents LE-DT Phase I data at the AACR conference

NeoPharm presents LE-DT Phase I data at the AACR conference

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

Phase II clinical study to evaluate Nanocort commenced

Phase II clinical study to evaluate Nanocort commenced

Erbitux recognized as one of the major clinical cancer advances of 2009

Erbitux recognized as one of the major clinical cancer advances of 2009

Nano-size capsule that boosts the body's uptake of curcumin being developed

Nano-size capsule that boosts the body's uptake of curcumin being developed

NeoPharma submits a Phase II protocol to the FDA for its liposome entrapped docetaxel study

NeoPharma submits a Phase II protocol to the FDA for its liposome entrapped docetaxel study

First Japanese patient treated in Celsion’s global Phase III ThermoDox HEAT trial

First Japanese patient treated in Celsion’s global Phase III ThermoDox HEAT trial